Cresco Labs Inc. (OTCMKTS:CRLBF) Given Consensus Rating of “Buy” by Brokerages

Shares of Cresco Labs Inc. (OTCMKTS:CRLBFGet Rating) have been assigned a consensus rating of “Buy” from the nine analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $21.67.

A number of equities research analysts have recently weighed in on the company. Canaccord Genuity Group dropped their target price on Cresco Labs from C$15.00 to C$12.00 in a research report on Friday, March 25th. Atb Cap Markets reaffirmed an “outperform” rating on shares of Cresco Labs in a research report on Wednesday, March 23rd. Zacks Investment Research cut Cresco Labs from a “hold” rating to a “sell” rating in a research report on Monday. Finally, Piper Sandler reduced their price objective on Cresco Labs from $14.00 to $9.00 and set an “overweight” rating for the company in a research report on Thursday, March 24th.

CRLBF stock opened at $3.91 on Friday. Cresco Labs has a 1-year low of $3.82 and a 1-year high of $12.88. The business’s 50 day moving average is $5.41 and its 200-day moving average is $6.66.

Cresco Labs Company Profile (Get Rating)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand.

Featured Stories

Analyst Recommendations for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with's FREE daily email newsletter.